SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-049871
Filing Date
2024-12-18
Accepted
2024-12-18 20:19:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9855
  Complete submission text file 0001140361-24-049871.txt   11539
Mailing Address 333 SOUTH GRAND AVENUE 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE 28TH FLOOR LOS ANGELES CA 90071 (213) 830-6300
Oaktree Capital Group Holdings GP, LLC (Filed by) CIK: 0001403525 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90437 | Film No.: 241560719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)